文献速递前列腺癌

多灶性原发性前列腺癌呈现高度基因组异质性

Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
PubMed 文献 · Eur Urol · 2018-09-01

该研究对41例患者的前列腺切除标本中89个肿瘤灶及非癌组织进行高覆盖全外显子组测序,发现同一前列腺内不同肿瘤灶间基因组高度异质;76%的成对比较肿瘤灶无共同点突变,拷贝数改变也罕见共享。结论提示基于基因组信息管理前列腺癌需综合所有肿瘤灶信息。

要点

  • 同一前列腺内不同肿瘤灶基因组高度异质,76%成对比较无共同点突变。
  • 肿瘤灶间共享的点突变极少涉及癌症关键基因,拷贝数改变也罕见共享。
  • 基于基因组信息管理前列腺癌需综合所有肿瘤灶信息才能得出有效结论。

核心结论

  • 同一患者前列腺内不同肿瘤灶在遗传上不同,仅罕见共享体细胞基因突变包括癌症驱动基因突变。
  • 这种异质性影响基于基因组的前列腺癌管理实施,需所有肿瘤灶信息才能得出关于癌症基因组改变的有效结论。

研究设计与样本

  • 对41例患者的前列腺切除标本中2至3个不同肿瘤灶及1个非癌区域共153份冰冻组织样本进行高覆盖全外显子组测序,覆盖89个肿瘤灶。

主要发现

  • 同一前列腺切除标本中76%的成对比较肿瘤灶无共同点突变。
  • DNA拷贝数改变在癌灶间罕见共享。
  • 癌灶间共享的少数点突变极少位于癌症关键基因。

临床怎么用

  • 基于基因组信息管理前列腺癌时需综合所有肿瘤灶信息,因每个肿瘤灶的突变使其独特,需考虑以获最佳治疗结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most primary prostate cancers are multifocal with individual tumors harboring different aggressiveness; however, the genomic heterogeneity among these tumors is poorly understood. OBJECTIVE: To better understand the biological basis for clinical variability among different lesions, we sought to comprehensively characterize the heterogeneity of somatic gene mutations in multifocal prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: High-coverage whole-exome sequencing of 153 frozen tissue samples, taken from two to three distinct tumor foci and one non-cancerous area from each of 41 patients, covering a total of 89 tumor foci. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: State-of-the-art bioinformatics tools for mutation calling and copy number determination from whole-exome sequencing data. RESULTS AND LIMITATIONS: We found a very high degree of interfocal heterogeneity among tumors, that is, 76% of pairwise-compared tumor foci from the same prostatectomy specimen had no point mutations in common and DNA copy number changes were rarely shared across cancer foci. The few point mutations shared across tumor foci were seldom in cancer-critical genes. CONCLUSIONS: In this first large genomic heterogeneity study of primary prostate cancer, we observe that different tumor foci within the same patient are genetically distinct, only rarely sharing any somatic gene mutations, including those in cancer driver genes. This heterogeneity affects how genomics-based management of prostate cancer can be implemented, as information from all tumor foci is necessary to draw valid conclusions about the cancer's genomic alterations. PATIENT SUMMARY: Most primary prostate cancers consist of multiple tumors within the same organ, but little is known about their relationships. We have compared the sets of gene mutations among such tumors and found that they only exceptionally have any in common. This will influence treatment decisions in the future as each tumor's mutations will render it unique and have to be considered to gain the best treatment results.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Løvf M, Zhao S, Axcrona U, et al. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity. Eur Urol. 2018. PMID: 30181068. doi:10.1016/j.eururo.2018.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。